Haemonetics Corp
NYSE:HAE

Watchlist Manager

Haemonetics Corp

NYSE:HAE

Watchlist

Dividends

Price: 92.11 USD 0.36%

Market Cap: 4.7B USD

Have any thoughts about
Haemonetics Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 92.11 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

HAE Alert

Haemonetics Corp

92.11

+0.33 (+0.36%)

52 Week Range	71.16 97.37
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Haemonetics Corp

What unique competitive advantages
does Haemonetics Corp hold over its rivals?

What risks and challenges
does Haemonetics Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Haemonetics Corp.

What unique competitive advantages
does Haemonetics Corp hold over its rivals?

What risks and challenges
does Haemonetics Corp face in the near future?

Summarize the latest earnings call
of Haemonetics Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Haemonetics Corp.

Provide P/S
for Haemonetics Corp.

Provide P/E
for Haemonetics Corp.

Provide P/OCF
for Haemonetics Corp.

Provide P/FCFE
for Haemonetics Corp.

Provide P/B
for Haemonetics Corp.

Provide EV/S
for Haemonetics Corp.

Provide EV/GP
for Haemonetics Corp.

Provide EV/EBITDA
for Haemonetics Corp.

Provide EV/EBIT
for Haemonetics Corp.

Provide EV/OCF
for Haemonetics Corp.

Provide EV/FCFF
for Haemonetics Corp.

Provide EV/IC
for Haemonetics Corp.

Show me price targets
for Haemonetics Corp made by professional analysts.

What are the Revenue projections
for Haemonetics Corp?

How accurate were the past Revenue estimates
for Haemonetics Corp?

What are the Net Income projections
for Haemonetics Corp?

How accurate were the past Net Income estimates
for Haemonetics Corp?

What are the EPS projections
for Haemonetics Corp?

How accurate were the past EPS estimates
for Haemonetics Corp?

What are the EBIT projections
for Haemonetics Corp?

How accurate were the past EBIT estimates
for Haemonetics Corp?

Compare the revenue forecasts
for Haemonetics Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Haemonetics Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Haemonetics Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Haemonetics Corp compared to its peers.

Compare the P/E ratios
of Haemonetics Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Haemonetics Corp with its peers.

Analyze the financial leverage
of Haemonetics Corp compared to its main competitors.

Show all profitability ratios
for Haemonetics Corp.

Provide ROE
for Haemonetics Corp.

Provide ROA
for Haemonetics Corp.

Provide ROIC
for Haemonetics Corp.

Provide ROCE
for Haemonetics Corp.

Provide Gross Margin
for Haemonetics Corp.

Provide Operating Margin
for Haemonetics Corp.

Provide Net Margin
for Haemonetics Corp.

Provide FCF Margin
for Haemonetics Corp.

Show all solvency ratios
for Haemonetics Corp.

Provide D/E Ratio
for Haemonetics Corp.

Provide D/A Ratio
for Haemonetics Corp.

Provide Interest Coverage Ratio
for Haemonetics Corp.

Provide Altman Z-Score Ratio
for Haemonetics Corp.

Provide Quick Ratio
for Haemonetics Corp.

Provide Current Ratio
for Haemonetics Corp.

Provide Cash Ratio
for Haemonetics Corp.

What is the historical Revenue growth
over the last 5 years for Haemonetics Corp?

What is the historical Net Income growth
over the last 5 years for Haemonetics Corp?

What is the current Free Cash Flow
of Haemonetics Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Haemonetics Corp.

P/OCF
Price to OCF

54.4

Current

19.1

Median

14.9

Industry

Higher than median

Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF

54.4

Market Cap

4.6B USD

Operating Cash Flow

85m USD

All Countries

Forward Multiples

			Market Cap	P/OCF
US		Haemonetics Corp NYSE:HAE	4.6B USD	54.4
JP		Hoya Corp TSE:7741	7T JPY	31.7
CH		Alcon AG SIX:ALC	37.8B CHF	23.1
DK		Coloplast A/S CSE:COLO B	205.9B DKK	74.5
US		Align Technology Inc NASDAQ:ALGN	16B USD	31
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	53.9B CNY	35.7
CA		Bausch + Lomb Corp NYSE:BLCO	7B USD	30.9
UK		ConvaTec Group PLC LSE:CTEC	5.3B GBP	18.7
CH		Ypsomed Holding AG SIX:YPSN	5.2B CHF	32.1
US		Merit Medical Systems Inc NASDAQ:MMSI	5.9B USD	27.6
KR	H	HLB Inc KOSDAQ:028300	8T KRW	-55.5


US		Haemonetics Corp NYSE:HAE	Average P/OCF: 36 54.4
JP		Hoya Corp TSE:7741	31.7
CH		Alcon AG SIX:ALC	23.1
DK		Coloplast A/S CSE:COLO B	74.5
US		Align Technology Inc NASDAQ:ALGN	31
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	35.7
CA		Bausch + Lomb Corp NYSE:BLCO	30.9
UK		ConvaTec Group PLC LSE:CTEC	18.7
CH		Ypsomed Holding AG SIX:YPSN	32.1
US		Merit Medical Systems Inc NASDAQ:MMSI	27.6
KR	H	HLB Inc KOSDAQ:028300	Negative Multiple: -55.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/OCF

N/A

2-Years Forward

P/OCF

N/A

3-Years Forward

P/OCF

N/A

Haemonetics Corp
NYSE:HAE

P/OCF
Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Haemonetics Corp NYSE:HAE

P/OCF Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Haemonetics Corp
NYSE:HAE

P/OCF
Price to OCF